(Q37553140)

English

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

scientific article published on 18 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

3 references

13 March 2019

22 April 2019

17 June 2019

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

3 references

13 March 2019

22 April 2019

17 June 2019

0 references

systematic review

1 reference

based on heuristic

inferred from title

Rachelle Buchbinder

14

object named as

Rachelle Buchbinder

0 references

Ulf Müller-Ladner

26

object named as

Ulf Müller-Ladner

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Rubén Burgos-Vargas

19

object named as

Rubén Burgos-Vargas

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Carlomaurizio Montecucco

25

object named as

Carlomaurizio Montecucco

0 references

object named as

Jaime C Branco

18

0 references

object named as

Louise Falzon

29

0 references

Mihir D Wechalekar

object named as

Mihir D Wechalekar

11

0 references

Mariano Andrés

object named as

Mariano Andrés

2

0 references

object named as

Loreto Carmona

3

0 references

20

object named as

Anca I Catrina

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

12

object named as

Daniel Aletaha

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Claire Bombardier

13

object named as

Claire Bombardier

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Francisca Sivera

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Alison S R Kydd

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

John Moi

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Rakhi Seth

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Melonie Sriranganathan

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Caroline van Durme

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Irene van Echteld

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Ophir Vinik

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Christopher J Edwards

15

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Robert B Landewé

16

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Johannes W Bijlsma

17

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Dirk Elewaut

21

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Antonio J L Ferrari

22

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Patrick Kiely

23

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Burkhard F Leeb

24

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Mikkel Ostergaard

27

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Jane Zochling

28

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Désirée M van der Heijde

30

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

18 July 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1 February 2014

3 references

13 March 2019

22 April 2019

17 June 2019

Annals of the Rheumatic Diseases

4 references

Europe PubMed Central

PMC publication ID

21 August 2017

13 March 2019

22 April 2019

17 June 2019

73

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

328-335

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

copyright license

Creative Commons Attribution-NonCommercial

3 references

13 March 2019

22 April 2019

17 June 2019

on focus list of Wikimedia project

0 references

Interventions for tophi in gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Dietary supplements for chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Non-steroidal anti-inflammatory drugs for acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Interleukin-1 inhibitors for acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Lifestyle interventions for chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Intra-articular glucocorticoids for acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Epidemiology of gout: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Serum uric acid levels and the risk of type 2 diabetes: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Effects of evidence-based clinical practice guidelines on quality of care: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Treating to target: a strategy to cure gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Risk factors for end-stage renal disease: 25-year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

The effect of serum urate on gout flares and their associated costs: an administrative claims analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Therapeutic advances in gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Serum urate levels and gout flares: analysis from managed care data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Evaluation of the quality of prognosis studies in systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Effectiveness and efficiency of guideline dissemination and implementation strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Hyperuricaemia and gout: clinical guideline 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Relation between adverse events associated with allopurinol and renal function in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Comparison of indomethacin and phenylbutazone in acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Multicentre trial of naproxen and phenylbutazone in acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

23 August 2017

Gout: why is this curable disease so seldom cured?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Long-term cardiovascular mortality among middle-aged men with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Does colchicine work? The results of the first controlled study in acute gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

6 September 2017

The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

14 September 2017

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

14 September 2017

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

28 September 2017

Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

28 September 2017

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

25 June 2018

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

25 June 2018

Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

25 June 2018

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Gout: an independent risk factor for all-cause and cardiovascular mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Outcome domains for studies of acute and chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Quality of life and disability in patients with treatment-failure gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Validation of the Health Assessment Questionnaire disability index in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Serum uric acid and risk of ischemic stroke: the ARIC Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Summary of the Dutch College of General Practitioners' "Gout" Standard

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

1 September 2018

Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

2 October 2018

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

2 October 2018

Ultrasonographic measurement of tophi as an outcome measure for chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913257

2 October 2018

A Diagnostic Rule for Acute Gouty Arthritis in Primary Care Without Joint Fluid Analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203325

21 January 2018

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203325

21 January 2018

Piroxicam in treatment of acute gout high dose versus low dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tenoxicam in patients with acute gouty arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gout and coronary heart disease: the Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flurbiprofen in the treatment of acute gout. A comparison with indomethacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computed tomography measurement of tophus volume: comparison with physical measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Phenylbutazone and Flufenamic Acid in the Treatment of Acute Gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2011 Recommendations for the diagnosis and management of gout and hyperuricemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23868909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2013-203325

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

release_txcd6y2lmfeofdrx65webyan2u

1 reference

https://api.fatcat.wiki/v0/release/txcd6y2lmfeofdrx65webyan2u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37553140&oldid=1842480971"